Gilead Sciences Inc (GILD)

Lima


	Symbol		Exchange		Currency
	GILD		NASDAQ		USD	Real-time
	0QYQ		London		USD	Real-time
	GILD		Mexico		MXN	Delayed
	GGILD		Milan		EUR	Real-time
	GILD		Xetra		EUR	Delayed
	GILD		Frankfurt		EUR	Delayed
	GILD		TradeGate		EUR	Delayed
	GILDm		Buenos Aires		ARS	Delayed
	GILD34		B3		BRL	Delayed
	GILD		Vienna		EUR	Real-time
	GILD		Lima		USD	Delayed

Currency in USD

Disclaimer

82.75

-0.75(-0.90%)

Closed17/09

Fair Value

Day's Range

82.75

82.75

52 wk Range

69.47

83.50

GILD Income Statement

Featured here, the Income Statement (earnings report) for Gilead Sciences Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

22,449

24,689

27,305

27,281

27,116

Total Revenues Growth

+1.46%

+9.98%

+10.6%

-0.09%

-0.6%

Cost Of Revenues

4,675

3,691

5,526

5,657

6,019

Gross Profit

17,774

20,998

21,779

21,624

21,097

Gross Profit Growth

+2.89%

+18.14%

+3.72%

-0.71%

-2.44%

Gross Profit Margin %

79.18%

85.05%

79.76%

79.26%

77.8%

Other Operating Expenses, Total

8,436

10,039

9,847

10,671

11,295

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.77%	+19%	-1.91%	+8.37%	+5.85%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,055	4,927	4,601	4,998	5,758
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,381	5,112	5,246	5,673	5,537
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

9,338

10,959

11,932

10,953

9,802

Operating Income Growth

+0.43%

+17.36%

+8.88%

-8.2%

-10.51%

EBIT Margin %

41.6%

44.39%

43.7%

40.15%

36.15%

Net Interest Expenses

-995

-984

-1,001

-559

-568

Net Interest Expenses Growth

+7.61%

+1.11%

-1.73%

+44.16%

-1.61%

Interest Expense, Total

-995

-984

-1,001

-935

-944

Interest And Investment Income

-

-

-

376

376

Other Non Operating Expenses, Total

627

244

-29

-300

-10

EBT, Excl. Unusual Items

8,970

10,219

10,902

10,094

9,224

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-5,051

-5,968

-2,014

-3,623

-1,670

EBT, Incl. Unusual Items

5,160

1,669

8,278

5,814

6,860

EBT, Incl. Unusual Items Growth

-33.84%

-67.66%

+395.99%

-29.77%

+17.99%

EBT, Incl. Unusual Items Margin

22.99%

6.76%

30.32%

21.31%

25.3%

Income Tax Expense

-204

1,580

2,077

1,248

1,247

Net Income to Company

5,364

89

6,201

4,566

5,613

Minority Interest

22

34

24

26

52

Net Income

5,386

123

6,225

4,592

5,665

Net Income Growth

-1.26%

-97.72%

+4,960.98%

-26.23%

+23.37%

Net Income Margin %

23.99%

0.5%

22.8%

16.83%

20.89%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

5,386

123

6,225

4,592

5,665

Basic EPS - Continuing Operations

4.24

0.1

4.96

3.66

4.54

Basic EPS - Continuing Operations Growth

+0.91%

-97.69%

+4,965.01%

-26.17%

+24.06%

Diluted EPS - Continuing Operations

4.22

0.1

4.93

3.64

4.5

Diluted EPS - Continuing Operations Growth

+1.2%

-97.68%

+4,938.22%

-26.17%

+23.63%

Basic Weighted Average Shares Outstanding

1,270

1,257

1,256

1,255

1,248

Diluted Weighted Average Shares Outstanding

1,277

1,263

1,262

1,262

1,258

Dividend Per Share

2.52

2.72

2.84

2.92

3

Dividend Per Share Growth

+10.53%

+7.94%

+4.41%

+2.82%

+2.74%

EBITDA

10,742

12,439

13,982

13,056

12,495

EBITDA Growth

+0.14%

+15.8%

+12.4%

-6.62%

-4.3%

EBITDA Margin %

47.85%

50.38%

51.21%

47.86%

46.08%

EBIT